Clinical Comparison of Two Resin Composites on Diastema Closure and Reshaping at Four Years
Launched by HACETTEPE UNIVERSITY · Sep 7, 2016
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study was to evaluate the clinical performances of nano-hybrid resin composite systems used for anterior diastema closure and tooth reshaping at 4 years in service using FDI Criteria.
The study protocol was approved by the Ethical Committee of Hacettepe University, Ankara, Turkey and the Ethical Committee of Ministry of Health (protocol HEK KA-14004). A total of 23 patients (6 male, 17 female, mean age: 31.27) with maxillary anterior midline or multi-diastema problem received 76 direct composite resin restorations.
The teeth to be restored were first cleaned with pumice-wa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all subjects were required to be at least 18 years old,
- • able to read and sign the informed consent document,
- • physically and psychologically able to tolerate conventional restorative procedures,
- • having no active periodontal or pulpal diseases,
- • having teeth with good restorations, and
- • willing to return for follow-up examinations as outlined by the investigators.
- Exclusion Criteria:
- • uncontrolled parafunction;
- • insufficient oral hygiene leading to caries lesions more than twice yearly during the previous 2 years;
- • being pregnant or nursing; and
- • having periodontal or gingival disease.
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Sevil Gurgan, PhD, DDS
Study Director
Hacettepe University School of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials